Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results
Titel:
Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results
Auteur:
Chamoun, Kamal Milton, Denái R. Ledesma, Celina Young, Ken H. Jabbour, Elias J. Alatrash, Gheath Anderlini, Paolo Bashir, Qaiser Ciurea, Stefan O. Marin, David Molldrem, Jeffrey J. Olson, Amanda L. Oran, Betul Popat, Uday R. Rondon, Gabriela Champlin, Richard E. Gulbis, Alison M. Khouri, Issa F.
Verschenen in:
Biology of blood and marrow transplantation
Paginering:
Jaargang 25 (2019) nr. 7 pagina's 1347-1354
Jaar:
2019
Inhoud:
Uitgever:
American Society for Blood and Marrow Transplantation